Inventor · disambiguated record
Martijn Fenaux
Also filed as: FENAUX MARTIJN
17 granted patents·18 pending applications·247 citations·filing 2002–2025
93Inventor score
Files withTERNS PHARMACEUTICALS INC20MENG XIANG JIN4NOVARTIS AG3VIRGINIA TECH INTELL PROP3UNIV IOWA STATE RES FOUND INC2
Top patents by PatentIndex Score
35 records- 0197US7279166B2Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereofUNIV IOWA STATE RES FOUND INC·Filed 2004·Granted Oct 9, 2007·123 cites·26 claims
- 0296US12378239B2Compounds as GLP-1R agonistsTERNS PHARMACEUTICALS INC·Filed 2025·Granted Aug 5, 2025·1 cites·20 claims
- 0396US12378237B2Compounds as GLP-1R agonistsTERNS PHARMACEUTICALS INC·Filed 2025·Granted Aug 5, 2025·1 cites·20 claims
- 0496US12378236B2Compounds as GLP-1R agonistsTERNS PHARMACEUTICALS INC·Filed 2025·Granted Aug 5, 2025·1 cites·20 claims
- 0596US12378238B2Compounds as GLP-1R agonistsTERNS PHARMACEUTICALS INC·Filed 2025·Granted Aug 5, 2025·1 cites·20 claims
- 0696US12024507B2Compounds as GLP-1R agonistsTERNS PHARMACEUTICALS INC·Filed 2022·Granted Jul 2, 2024·14 cites·32 claims
- 0795US7575752B2Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereofVIRGINIA TECH INTELL PROP·Filed 2007·Granted Aug 18, 2009·30 cites·5 claims
- 0893US7276353B2Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereofUNIV IOWA STATE RES FOUND INC·Filed 2002·Granted Oct 2, 2007·66 cites·2 claims
- 0986US2025282772A1Compounds as glp-1r agonistsTERNS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1084US9814739B22′-ethynyl nucleoside derivatives for treatment of viral infectionsNOVARTIS AG·Filed 2016·Granted Nov 14, 2017·2 cites·10 claims
- 1181US9889187B2Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereofMENG XIANG JIN·Filed 2015·Granted Feb 13, 2018·2 cites·20 claims
- 1280US2023150998A1Compounds as glp-1r agonistsTERNS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1380US2024316025A1Combination treatment of liver disordersTERNS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1477US12486261B2Compounds as GLP-1R agonistsTERNS PHARMACEUTICALS INC·Filed 2024·Granted Dec 2, 2025·0 cites·46 claims
- 1576US8058048B2Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereofMENG XIANG-JIN·Filed 2009·Granted Nov 15, 2011·1 cites·9 claims
- 1676US2025099468A1Treating liver disorders with an ssao inhibitorTERNS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1775US10428105B2Alkynyl nucleoside analogs as inhibitors of human rhinovirusNOVARTIS AG·Filed 2018·Granted Oct 1, 2019·1 cites·16 claims
- 1875US9556216B22′-Ethynyl nucleoside derivatives for treatment of viral infectionsANANDAN SAMPATH-KUMAR·Filed 2013·Granted Jan 31, 2017·2 cites·15 claims
- 1975US2024000765A1Combination treatment of liver disordersTERNS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2073US9211324B2Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereofMENG XIANG-JIN·Filed 2011·Granted Dec 15, 2015·1 cites·7 claims
- 2172US9988416B2Alkynyl nucleoside analogs as inhibitors of human rhinovirusNOVARTIS AG·Filed 2017·Granted Jun 5, 2018·1 cites·15 claims
- 2269US2023181583A1Treating liver disorders with an ssao inhibitorTERNS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2368US2021379043A1Combination treatment of liver disordersTERNS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2467US10507238B2Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereofMENG XIANG JIN·Filed 2018·Granted Dec 17, 2019·0 cites·21 claims
- 2563US2022089578A1Compounds as glp-1r agonistsTERNS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2663US2023322744A1Compounds as glp-1r agonistsTERNS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2762US2023241071A1Combination treatment of liver disordersTERNS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2857US2003096377A1Differential PCR-RFLP assay for detecting and distinguishing between nonpathogenic PCV-1 and pathogenic PCV-2VIRGINIA TECH INTELL PROP·Filed 2002·Application pending·0 cites
- 2956US2005147966A1Differential PCR-RFLP assay for detecting and distinguishing between nonpathogenic PCV-1 and pathogenic PCV-2VIRGINIA TECH INTELL PROP·Filed 2005·Application pending·0 cites
- 3056US2024059682A1Thyroid hormone receptor beta agonist compoundsTERNS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3154US2021379040A1Combination treatment of liver disordersTERNS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3252US2023127498A1Treatment of respiratory disordersTERNS INC·Filed 2021·Application pending·0 cites
- 3351US2022387414A1Treating liver disordersTERNS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3450US2022241312A1Compounds for treating cancerTEMS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3548US2021244744A1Treating liver disordersTERNS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Martijn Fenaux files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →